Consumer Group Seeks Enforcement Action Against Multiple Supplement Firms
November 27, 2019 at 08:17 AM EST
The Center for Science in the Public Interest (CSPI) is urging the FDA and Federal Trade Commission (FTC) to “pursue enforcement action” against 27 manufacturers who are marketing 39 supplements in a manner that “explicitly or implicitly” claim that the products “treat female infertility.” Products marketed to address infertility are considered drugs under the Federal Food, Dr... Read More
